Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma

<p>Cluster defining genes from scRNAseq data</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Isha Mondal (16721699) (author)
مؤلفون آخرون:	Oishika Das (16721702) (author), Raymond Sun (16721705) (author), Jian Gao (16721708) (author), Bohyeon Yu (16721711) (author), Aaron Diaz (16721714) (author), Jinan Behnan (16721717) (author), Abhishek Dubey (16721720) (author), Zhipeng Meng (16721723) (author), Emad Eskandar (16721726) (author), Beisi Xu (14941098) (author), Rongze Olivia Lu (16721729) (author), Winson S. Ho (16721732) (author)
منشور في:	2025
الموضوعات:	Cancer Tumor Biology Immuno-oncology CNS Cancers Gliomas, Glioblastomas Immunology Immune responses to cancer Immunotherapy Combination immunotherapy Tumor Microenvironment Immune cells and the microenvironment
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
حسب: Min Wu (14962986)
منشور في: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
حسب: Min Wu (14962986)
منشور في: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
حسب: Min Wu (14962986)
منشور في: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
حسب: Min Wu (14962986)
منشور في: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Suppl video 4 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Supplementary Table 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
حسب: Francisco Hermida-Prado (14958909)
منشور في: (2025)

Figure S1 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
حسب: Michael Kilian (16697663)
منشور في: (2025)

Figure S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
حسب: Michael Kilian (16697663)
منشور في: (2025)

Figure S3 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
حسب: Michael Kilian (16697663)
منشور في: (2025)

Supplementary Tables S1-S4 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
حسب: Axel Stenmark Tullberg (15029928)
منشور في: (2025)

Table S1 from HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden–induced T-cell Exhaustion
حسب: Andrew Nguyen (17142197)
منشور في: (2025)

Figure S1 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
حسب: Li-Li Long (14963775)
منشور في: (2025)

Figure S2 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
حسب: Li-Li Long (14963775)
منشور في: (2025)

Figure S3 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
حسب: Li-Li Long (14963775)
منشور في: (2025)

Figure S4 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
حسب: Li-Li Long (14963775)
منشور في: (2025)

Figure S5 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
حسب: Li-Li Long (14963775)
منشور في: (2025)

Figure S6 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
حسب: Li-Li Long (14963775)
منشور في: (2025)

Figure S7 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
حسب: Li-Li Long (14963775)
منشور في: (2025)

Supplementary Table 1 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
حسب: Li-Li Long (14963775)
منشور في: (2025)

Supplementary Table 2 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
حسب: Li-Li Long (14963775)
منشور في: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
حسب: Kankan Cao (16437263)
منشور في: (2025)

Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
حسب: Carlotta Antoniotti (15352506)
منشور في: (2025)

Supplementary Figure S2 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
حسب: Carlotta Antoniotti (15352506)
منشور في: (2025)

Supplementary Figure S3 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
حسب: Carlotta Antoniotti (15352506)
منشور في: (2025)

Figure 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
حسب: Clare Vesely (505402)
منشور في: (2025)

Figure 2 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
حسب: Clare Vesely (505402)
منشور في: (2025)

Figure 3 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
حسب: Clare Vesely (505402)
منشور في: (2025)

Figure 4 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
حسب: Clare Vesely (505402)
منشور في: (2025)

Figure 5 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
حسب: Clare Vesely (505402)
منشور في: (2025)

Table 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
حسب: Clare Vesely (505402)
منشور في: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
حسب: Erika Y. Faraoni (14844897)
منشور في: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
حسب: Erika Y. Faraoni (14844897)
منشور في: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
حسب: Erika Y. Faraoni (14844897)
منشور في: (2025)

Supplementary Data S1 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
حسب: Maria Lozano-Rabella (15056515)
منشور في: (2025)

Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
حسب: Maria Lozano-Rabella (15056515)
منشور في: (2025)

Supplementary Data S3 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
حسب: Maria Lozano-Rabella (15056515)
منشور في: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ghipm71hq4d3gvtuidshcvil10